(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-20 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 939570
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Thu Jun 2024 | 2.95 | 3.00 | 3.01 | 2.92 | 1.373 times |
| 18 Tue Jun 2024 | 3.01 | 3.07 | 3.07 | 3.01 | 0.746 times |
| 18 Tue Jun 2024 | 3.01 | 3.07 | 3.07 | 3.01 | 0.746 times |
| 17 Mon Jun 2024 | 3.06 | 3.15 | 3.15 | 3.05 | 0.692 times |
| 14 Fri Jun 2024 | 3.14 | 3.13 | 3.17 | 3.11 | 0.632 times |
| 13 Thu Jun 2024 | 3.16 | 3.25 | 3.26 | 3.14 | 0.693 times |
| 12 Wed Jun 2024 | 3.25 | 3.25 | 3.31 | 3.23 | 1.03 times |
| 11 Tue Jun 2024 | 3.18 | 3.12 | 3.21 | 3.08 | 1.06 times |
| 10 Mon Jun 2024 | 3.14 | 3.19 | 3.21 | 3.11 | 1.259 times |
| 07 Fri Jun 2024 | 3.20 | 3.31 | 3.31 | 3.12 | 1.412 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 2.9, for a target of 3.1 or 3.25
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 2.27 |
| Downside Target | 2.42 |
| Downside Target | 2.63 |
| Downside Target | 2.81 |
| Downside Target | 2.92 |
| Upside Target | 3.25 |
| Upside Target | 3.29 |
| Upside Target | 3.31 |
| Upside Target | 3.39 |
| Upside Target | 3.44 |
| Upside Target | 3.64 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 2.89 |
| Downside Intraday Target | 2.83 |
| Upside Intraday Target | 3.04 |
| Upside Intraday Target | 3.13 |
| Upside Intraday Target | 2.98 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Thu Jun 2024 | 2.95 | 3.07 | 3.07 | 2.92 | 1.474 times |
| 18 Tue Jun 2024 | 3.01 | 3.15 | 3.15 | 3.01 | 0.308 times |
| 14 Fri Jun 2024 | 3.14 | 3.19 | 3.31 | 3.08 | 0.647 times |
| 07 Fri Jun 2024 | 3.20 | 3.36 | 3.64 | 3.12 | 1.508 times |
| 31 Fri May 2024 | 3.36 | 3.35 | 3.39 | 3.25 | 0.781 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Thu Jun 2024 | 2.95 | 3.36 | 3.64 | 2.92 | 0.794 times |
| 31 Fri May 2024 | 3.36 | 2.74 | 3.44 | 2.63 | 0.418 times |
| 30 Tue Apr 2024 | 2.73 | 2.61 | 3.29 | 2.30 | 3.526 times |
| 28 Thu Mar 2024 | 2.58 | 2.78 | 2.81 | 2.42 | 0.408 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.11 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.11 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.